Pre-Clinical mouse models of primary UNIT 14.21 and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden

Current Protocols in Pharmacology

Volumn , Issue SUPPL. 54, 2011, Pages

  Servais, Elliot L ^a   Colovos, Christos ^a   Kachala, Stefan S ^a   Adusumilli, Prasad S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bioluminescent imaging; Breast cancer; Malignant pleural disease; Malignant pleural effusion; Mesothelioma; Mouse model; Orthotopic

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MONITORING; BIOLUMINESCENCE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER MODEL; CANCER SURVIVAL; CELL SUSPENSION; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; PLEURA CANCER; PLEURA METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BREAST NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; LUNG NEOPLASMS; MESOTHELIOMA; MOLECULAR IMAGING; NEOPLASM METASTASIS; PATHOLOGY; PLEURAL NEOPLASMS; PROCEDURES; SECONDARY;

ANTINEOPLASTIC AGENT;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; MICE; MOLECULAR IMAGING; NEOPLASM METASTASIS; PLEURAL NEOPLASMS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84255201185     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph1421s54     Document Type: Article

References (18)

1. Adusumilli, P., Eisenberg, D., Stiles, B.M., Chung, S., Chan, M.K., Rusch, V.W., and Fong, Y. 2006a. Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus. J. Thorac. Cardiovasc. Surg. 132:1179-1188.
2. Adusumilli, P.S., Stiles, B.M., Chan, M.K., Mullerad, M., Eisenberg, D.P., Ben-Porat, L., Huq, R., Rusch, V.W., and Fong, Y. 2006b. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses. J. Gene Med. 8:603-615.
3. Antunes, G. Neville, E., Duffy, J, Ali, N., and Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. 2003. BTS guidelines for the management of malignant pleural effusions. Thorax 58:ii29-38.
4. Donovan, J. and Brown, P. 2006a. Euthanasia. Curr. Protoc. Immunol. 73:1.8.1-1.8.4.
5. Donovan, J. and Brown, P. 2006b. Parenteral injections. Curr. Protoc. Immunol. 73:1.6.1-1.6.10
6. Fenton, K.N. and Richardson, J.D. 1995. Diagnosis andmanagement ofmalignant pleural effusions. Am. J. Surg. 170:69-74.
7. Hoogstraten-Miller, S.L. and Brown, P.A. 2008. Techniques in aseptic rodent surgery. Curr. Protoc. Immunol. 82:1.12.1-1.12.14.
8. Manac'h, D., Riquet, M., Medioni, J., Le Pimpec-Barthes, F., Dujon, A., and Danel, C. 2001. Visceral pleura invasion by non-small cell lung cancer: An underrated bad prognostic factor. Ann. Thorac. Surg. 71:1088-1093.
9. Michailova, K.N. and Usunoff, K.G. 2006. Serosal membranes (pleura, pericardium, peritoneum). Normal structure, development and experimental pathology. Adv. Anat. Embryol. Cell Biol. 183:i-vii, 1-144, back cover.
10. Mishra, E. and Davies,R.J.O. 2010. Advances in the investigation and treatment of pleural effusions. Exp. Rev. Resp. Med. 4:123-133.
11. Newell, J. 2007. Guidelines for Survival Rodent Surgery. NIH-OACU, Bethesda, Md.
12. Osaki, T., Nagashima, A., Yoshimatsu, T., Yamada, S., and Yasumoto, K. 2004. Visceral pleural involvement in nonsmall cell lung cancer: Prognostic significance. Ann. Thorac. Surg. 77:1769-1773.
13. Phelan, M.C. 2006. Techniques for mammalian cell tissue culture. Curr. Protoc. Mol. Biol. 74:A.3F.1-A.3F.18.
14. Sahn, S.A. 2001. Malignant pleural effusions. Semin. Respir. Crit. Care Med. 22:607-616.
15. Shimizu, K., Yoshida, J., Nagai, K., Nishimura, M., Ishii, G. Morishita, Y., and Nishiwaki, Y. 2005. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 130:160-165.
16. Stathopoulos, G.T. and Kalomenidis, I. 2009. Animal models of malignant pleural effusion. Curr. Opin. Pulm. Med. 15:343-352.
17. Stiles, B.M., Adusumilli, P.S., Bhargava, A., Stanziale, S.F., Kim, T.H., Chan,M.K., Huq, R., Wong, R., Rusch, V.W., and Fong, Y. 2006. Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther. 13:53-64.
18. Zocchi, L. 2002. Physiology and pathophysiology of pleural fluid turnover. Eur. Respir. J. 20:1545-1558.